OOIR: Observatory of International Research

Papers

(The median citation count of Diabetes & Vascular Disease Research is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)

Article	Citations
Early detection of diabetic nephropathy in patient with type 2 diabetes mellitus: A review of the literature	93
Safety of four SGLT2 inhibitors in three chronic diseases: A meta-analysis of large randomized trials of SGLT2 inhibitors	52
Baicalin ameliorates atherosclerosis by inhibiting NLRP3 inflammasome in apolipoprotein E-deficient mice	32
Epigallocatechin-3-gallate ameliorates glucolipid metabolism and oxidative stress in type 2 diabetic rats	28
The impact of flash glucose monitoring on glycated hemoglobin in type 2 diabetes managed with basal insulin in Canada: A retrospective real-world chart review study	27
The association between sodium-glucose cotransporter 2 inhibitors and incident dementia: A nationwide population-based longitudinal cohort study	25
Comparative study of microvascular structural changes in the gestational diabetic placenta	20
Diabetes, metformin and glucose lowering therapies after myocardial infarction: Insights from the SWEDEHEART registry	15
Triglyceride-glucose index is prospectively associated with chronic kidney disease progression in Type 2 diabetes – mediation by pigment epithelium-derived factor	15
Low levels of circulating anti-ageing hormone Klotho predict the onset and progression of diabetic retinopathy	13
Plasma advanced glycation end products and soluble receptor for advanced glycation end products as indicators of sterol content in human carotid atherosclerotic plaques	11
Sleep behaviours and associated habits and the progression of pre-diabetes to type 2 diabetes mellitus in adults: A systematic review and meta-analysis	11
Impaired subendocardial perfusion in patients with metabolic syndrome	11
Cardiovascular outcomes and LDL-cholesterol levels in EMPA-REG OUTCOME^®	9
Impact of COVID-19 therapy on hyperglycemia	9
Vascular inflammation, atherosclerosis, and lipid metabolism and the occurrence of non-high albuminuria diabetic kidney disease: A cross-sectional study	9
Glucose variability is associated with an adverse vascular profile but only in the presence of insulin resistance in individuals with type 1 diabetes: An observational study	9
Plasma levels of tissue inhibitor of metalloproteinase-1 in patients with type 1 diabetes mellitus associate with early diabetic neuropathy and nephropathy	8
Impact of insulin therapy on outcomes of diabetic patients with heart failure: A systematic review and meta-analysis	8
Use of continuous glucose monitoring trend arrows in the younger population with type 1 diabetes	8
Extracellular vesicles in gestational diabetes mellitus: A scoping review	8
Shared and specific biological signalling pathways for diabetic retinopathy, peripheral neuropathy and nephropathy by high-throughput sequencing analysis	8
Deteriorated regional calf microcirculation measured by contrast-free MRI in patients with diabetes mellitus and relation with physical activity	8
Hyperinsulinemia alters insulin receptor presentation and internalization in brain microvascular endothelial cells	8
Association of triglyceride-glucose with cardiac hemodynamics in type 2 diabetes	7

Real life evaluation of sodium-glucose cotransporter 2 inhibition in type 1 diabetes and the risk of diabetic ketoacidosis	7
Silencing of FOS-like antigen 1 represses restenosis via the ERK/AP-1 pathway in type 2 diabetic mice	7
Genetic variation in CARD8, a gene coding for an NLRP3 inflammasome-associated protein, alters the genetic risk for diabetic nephropathy in the context of type 2 diabetes mellitus	7
TyG-BMI and hypertension in Normoglycemia subjects in Japan: A cross-sectional study	7
Endothelial deletion of PKCδ prevents VEGF inhibition and restores blood flow reperfusion in diabetic ischemic limb	7
DNA aptamer raised against receptor for advanced glycation end products suppresses renal tubular damage and improves insulin resistance in diabetic mice	7
Restoration of coronary microvascular function by OGA overexpression in a high-fat diet with low-dose streptozotocin-induced type 2 diabetic mice	7
Plasma proteomics reveals an improved cardio-metabolic profile in patients with type 2 diabetes post-liraglutide treatment	7
Accurate prediction of HbA1c by continuous glucose monitoring using a kinetic model with patient-specific parameters for red blood cell lifespan and glucose uptake	7
Glycaemic variability and risk of adverse cardiovascular events in acute coronary syndrome	6
Diabetes mellitus and the causes of hospitalisation in people with heart failure	6
Impact of diabetes on outcomes of cardiogenic shock: A systematic review and meta-analysis	6
Glucolipotoxicity induces endothelial cell dysfunction by activating autophagy and inhibiting autophagic flow	6
Triglyceride glucose index is independently associated with aortic intima-media thickness in patients without known atherosclerotic cardiovascular disease or diabetes	6
Mitochondrial mitophagy protection combining rivaroxaban and aspirin in high glucose-exposed human coronary artery endothelial cell. An in vitro study	6
Hyperglycemia compromises the ischemia-provoked dedifferentiation of cerebral pericytes through p21–SOX2 signaling in high-fat diet-induced murine model	6
Real-world study of flash glucose monitoring among adults with type 2 diabetes within the Swedish National Diabetes Register	6
Diabetes mellitus is associated with an increased incidence of aortic valve stenosis	6
SENP3 regulates high glucose-induced endothelial dysfunction via ROS dependent signaling	6
Impact of glucagon like peptide-1 receptor agonist and sodium glucose cotransporter 2 inhibitors on type 2 diabetes patients with renal impairment	6
Hypoglycemic agents and glycemic variability in individuals with type 2 diabetes: A systematic review and network meta-analysis	5
Effect of sotagliflozin as an adjunct to insulin therapy on blood pressure and arterial stiffness in adults with type 1 diabetes: A post hoc pooled analysis of inTandem1 and inTandem2	5
Roles of vascular endothelial and smooth muscle cells in the vasculoprotective effect of insulin in a mouse model of restenosis	5
Age-associated decline of monocyte insulin sensitivity in diabetic and healthy individuals	5
Risk factors for kidney disorders in patients with type 2 diabetes at high cardiovascular risk: An exploratory analysis (DEVOTE 12)	5
Insulin increases central aortic stiffness in response to hyperglycemia in healthy humans: A randomized four-arm study	5
Circulating microRNAs are associated with variability in fasting blood glucose over 12-months and target pathways related to type 2 diabetes: A pilot study	4
Coronary artery calcium score and coronary computed tomography angiography predict one-year mortality in patients with type 2 diabetes and peripheral artery disease undergoing partial foot amputation	4
Glucose-dependent insulinotropic polypeptide inhibits cardiac hypertrophy and fibrosis in diabetic mice via suppression of TGF-β2	4
Diabetic nephropathy ameliorated in patients with normal home blood pressure compared to those with isolated high home systolic blood pressure: A 5-year prospective cohort study among patients with ty	4
Alteration of autophagy-related protein 5 (ATG5) levels and Atg5 gene expression in diabetes mellitus with and without complications	4
Testosterone and sex hormone-binding globulin in dysglycemic women at high cardiovascular risk: A report from the Outcome Reduction with an Initial Glargine Intervention trial	4
Association of hemoglobin glycation index with prognosis of coronary artery disease after percutaneous coronary intervention: A retrospective cohort study	4
miR-1187 induces podocyte injury and diabetic nephropathy through autophagy	4
Lipoprotein (a) as a predictor of diabetic retinopathy in patients with type 2 diabetes: A systematic review	3
High serum Bhlhe40 levels are associated with subclinical atherosclerosis in patients with type 2 diabetes mellitus: A cross-sectional study	3
The relationship of neutrophil elastase and proteinase 3 with risk factors, and chronic complications in type 2 diabetes: A Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) sub-study	3
Cardiovascular safety of Glimepiride: An indirect comparison from CAROLINA and CARMELINA	3
Molecular mechanisms of diabetic heart disease: Insights from transcriptomic technologies	3
Renoprotective effects of combination treatment with sodium-glucose cotransporter inhibitors and GLP-1 receptor agonists in patients with type 2 diabetes mellitus according to preceding medication	3
Coronary revascularization in patients with stable coronary disease and diabetes mellitus	3
Comparison of symptomatic vertebrobasilar plaques between patients with and without Diabetes Mellitus using computed tomographic angiography and vessel wall magnetic resonance imaging	3
Growth factors in the fetus and pre-adolescent offspring of hyperglycemic rats	3
Dapagliflozin attenuates cardiac remodeling and dysfunction in rats with β-adrenergic receptor overactivation through restoring calcium handling and suppressing cardiomyocyte apoptosis	3